PT Enterprises Europe, Ltd.

We, in collaboration with other cancer-related organizations throughout the world, have a shared sense of purpose for eradicating this disease.

–

Driven by passion, dedication and a commitment to patient safety.

Committed to fighting the battle against cancer and other life threatening diseases.

Ensure the quality conduct of clinical trials so that safe and effective treatments will become available to those in need.

Work globally to assist Biotechnology and Pharmaceutical Companies to reach their goals of effective and safe treatment.

Extensive therapeutic area specialization in Oncology – optimized to work efficiently in this challenging area.

Well respected by investigators, site staff and sponsors alike in the international biopharmaceutical industry.

Project experience covers a wide range of solid and hematological tumor indications and therapeutic approaches.

Conduct thorough project feasibility assessments, enabling selection of the most appropriate countries and investigative sites to meet demands of specific recruitment targets and study timelines.

Develop innovative, efficient approaches to planning, implementing, conducting and monitoring the logistics of investigational clinical trials.

Preparation of audit responses for internal and external audits

Protocol development/CRF development.

Informed consent development and review.

Investigator Conference planning and presenting.

Develop and negotiate study center budgets.

Ensure that investigator and sponsor obligations are met in accordance with Food and Drug Administration (FDA) and International Council of Harmonization (ICH) Guidelines.

Assure and maintain Good Clinical Practice (GCP) at investigative sites.

Clear understanding of clinical research requirements on a global and local country level and have established excellent working relationships with an extensive network of oncology sites internationally.

Provide a responsive and collaborative approach to the Sponsor’s needs, with transparent business processes.

Protect the rights, safety, dignity and well-being of research participants.

Facilitate and promote ethical research that is of potential benefit to participants, science and society.

Oncology > Solid Tumor >Breast, Ovarian, Prostate, Lung, Colon, GI Stromal, Skin

Oncology >Hematological >Acute Myelogenous Leukemia, Chronic Lympocytic Leukemia, Myelodysplastic Syndrome, Mantle Cell Lymphoma

Pediatric Oncology > Microphthalmia Transcription Factor Associated Tumors

Central Nervous System > Alzheimer’s Disease, Bulimia, Depression, Schizophrenia

Cardiovascular > Acute Myocardial Infarction

HIV/AIDS > Anti-Retro Virals

Infectious Disease > Hepatitis C, Influenza

Endocrinology > Type II Diabetes

Auto-Immune Disease > Rheumatoid Arthritis

Rare Genetic Disease > Urea Cycle Disorder, Hereditary Inclusion Body Myopathy Disorder, Hepatic Encephalopathy

Pediatric Rare Genetic Disease > Urea Cycle Disorder

Oncology Related Anemia